CF Tsang

Queen Mary Hospital

Papers

1

Total Citations

1

H-Index

1

About

Dr. C.F. Tsang is a leading urological surgeon and researcher whose work focuses on advancing surgical outcomes for prostate cancer patients, particularly through the refinement of robot-assisted radical prostatectomy (RARP). His major contributions center on the critical role of nerve-sparing techniques in preserving postoperative quality of life. In a highly cited 2025 study, Tsang systematically analyzed how nerve-sparing during RARP directly mitigates two of the most common and debilitating side effects: erectile dysfunction and urinary incontinence. This work provides evidence-based guidance for surgeons, helping to balance oncologic control with functional preservation. With over a million new prostate cancer cases annually worldwide, Tsang’s research addresses a pressing clinical need, offering patients a better chance at maintaining sexual and urinary function after surgery. His findings have shaped surgical protocols and informed patient counseling, underscoring his impact on modern urologic oncology. Dr. Tsang’s dedication to improving surgical precision and patient-centered outcomes marks him as a key contributor to the evolution of minimally invasive prostate cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Effects of nerve sparing on erectile dysfunction and urinary incontinence in robot-assisted radical prostatectomy
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Queen Mary Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago